<?xml version="1.0" encoding="UTF-8"?>
<p>Developed at the University of Oxford, ChAdOx1 nCoV-19 is a safe version of an adenovirus. It has been modified so that it cannot be reproduced in the human body and the genetic code that transmits instructions for the production of Coronavirus Spike protein has been added, allowing the adenovirus to produce this protein after vaccination. The result is the formation of antibodies against Spike protein, known to be on the surface of SARS-CoV-2 (
 <xref rid="B92" ref-type="bibr">92</xref>).
</p>
